TP53 and breast carcinoma: As shown in the ATCC® database, tumor protein 53 mutations (TP53) in BT-549 (c.747G > C, at exon 7) and SK-BR-3 (c.524G > A, at exon 5) breast cancer cell lines were validated in our lab (Figure 2A).